Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
New and evolving concepts in the neurotoxicology of lead
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New and evolving concepts in the neurotoxicology of lead'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adult Neurogenesis
25%
Adverse Effects
25%
Alzheimer's Disease
25%
Alzheimer's Disease Pathology
25%
Amyloid beta
25%
Amyloid-β Protein Precursor (AβPP)
25%
Amyloidogenesis
25%
Astrocytes
50%
Astroglial Cells
25%
Biological Substrates
25%
Cell-type Specificity
25%
Cellular Growth
25%
Cellular Models
50%
Chaperone
75%
Cognitive Deficits
50%
Environmental Factors
25%
Essential Function
25%
Glucose-regulated Protein
25%
Glucose-regulated Protein 78 (GRP78)
100%
Glutamate Release
25%
Hippocampus
50%
Interleukin-6
50%
Later Life
25%
Lead Exposure
25%
Learning Impairment
25%
Learning Model
25%
Long-term Potentiation
25%
Low Socioeconomic Status
25%
Memory Models
25%
Mesocorticolimbic Dopamine System
25%
Molecular Chaperone
25%
Nervous System
50%
Nervous System Development
25%
Neurodegeneration
25%
Neurotoxicology
100%
NMDA Receptor Function
25%
Old Age
25%
Pb Exposure
25%
Protein Amyloids
25%
Protein Conformational Change
25%
Retention Time
25%
Rodents
50%
Structural Plasticity
50%
Synaptic Plasticity
50%
Targets of Interest
25%
Toxicology
25%
Xenobiotic Metals
25%
Biochemistry, Genetics and Molecular Biology
Amyloid Beta
50%
Amyloid Precursor Protein
50%
Astrocyte
100%
Cell Growth
50%
Cell Specificity
50%
Cytokine
50%
Glucocorticoid
100%
Glucose-Regulated Protein
50%
Glutamic Acid
50%
Interleukin 6
100%
Lead Poisoning
50%
Long Term Potentiation
50%
Nerve Cell Plasticity
100%
Nervous System Development
100%
Neurotoxicology
100%
NMDA Receptor
50%
Protein Associated with Alzheimer's Disease
50%
Retention Time
50%
Secretion (Process)
100%
Senescence
50%
Neuroscience
Adverse Effect
33%
Alzheimer's Disease
66%
Amyloid Precursor Protein
33%
Astrocyte
66%
Beta Amyloid
33%
Cell Growth
33%
Cell Specificity
33%
Chaperone
100%
Cognitive Disorders
66%
Glucocorticoid
66%
Glucose Regulated Protein
33%
Glucose Regulated Protein 78
33%
Glutamic Acid
33%
Hippocampus
66%
In Vitro
33%
Interleukin 6
66%
Learning Disabilities
33%
Long-Term Potentiation
33%
Nervous System
66%
Neurodegeneration
33%
Neurogenesis
66%
Neurotoxicology
100%
NMDA Receptor
33%
Senescence
33%
Synaptic Plasticity
66%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
33%
Alzheimer's Disease
66%
Amyloid Precursor Protein
33%
Amyloid Protein
33%
Chaperone
100%
Cognitive Defect
66%
Cytokine
33%
Disease
66%
Glucocorticoid
66%
Glucose Regulated Protein
33%
Glucose Regulated Protein 78
33%
Glutamic Acid
33%
Interleukin 6
66%
Lead Poisoning
33%
Learning Disorder
33%
N Methyl Dextro Aspartic Acid Receptor
33%
Nerve Degeneration
33%
Neurotoxicology
100%
Toxicology
33%
Xenobiotic Agent
33%